PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
503.87 - 512.55
344.79 - 555.45
23.62M / 20.39M (Avg.)
37.30 | 13.67
Shows the trajectory of a company's cash-generation capacity. Consistent growth in operating and free cash flow suggests a robust, self-funding business model—crucial for value investors seeking undervalued, cash-rich opportunities.
-18.52%
Negative net income growth while BB stands at 90.39%. Joel Greenblatt would see a comparative disadvantage in bottom-line performance.
38.80%
Some D&A expansion while BB is negative at -34.73%. John Neff would see competitor’s short-term profit advantage unless expansions here deliver big returns.
-94.21%
Negative yoy deferred tax while BB stands at 62.35%. Joel Greenblatt would consider near-term tax obligations but a possible advantage if competitor's deferrals become a burden later.
2.66%
Less SBC growth vs. BB's 50.00%, indicating lower equity issuance. David Dodd would confirm the firm still retains key staff.
11.69%
Slight usage while BB is negative at -158.86%. John Neff would note competitor possibly capturing more free cash unless expansions are needed here.
-314.43%
Both yoy AR lines negative, with BB at -46.11%. Martin Whitman would suspect an overall sector lean approach or softer demand.
38.58%
Some inventory rise while BB is negative at -98.54%. John Neff would see competitor possibly benefiting from leaner stock if demand remains.
220.53%
AP growth well above BB's 27.37%. Michael Burry would be concerned about potential late payments or short-term liquidity strain relative to competitor.
66.68%
Some yoy usage while BB is negative at -261.32%. John Neff would see competitor possibly generating more free cash from minor accounts than we do.
-13.50%
Both negative yoy, with BB at -85.00%. Martin Whitman would suspect an overall environment of intangible cleanup or shifting revaluations for the niche.
-5.79%
Both yoy CFO lines are negative, with BB at -596.30%. Martin Whitman would suspect cyclical or cost factors harming the entire niche’s cash generation.
-11.58%
Both yoy lines negative, with BB at -1.79%. Martin Whitman would suspect a cyclical or broad capital spending slowdown in the niche.
-3483.44%
Negative yoy acquisition while BB stands at 3.85%. Joel Greenblatt sees potential short-term cash advantage unless competitor’s deals yield big synergy.
-10.08%
Both yoy lines negative, with BB at -129.58%. Martin Whitman would suspect an environment with fewer attractive securities or a strategic pivot to internal growth.
18.61%
We have some liquidation growth while BB is negative at -45.21%. John Neff notes a short-term liquidity advantage if competitor is holding or restricted.
-613.04%
We reduce yoy other investing while BB is 17.09%. Joel Greenblatt sees a near-term cash advantage unless competitor’s intangible or side bets produce strong returns.
-107.98%
Both yoy lines negative, with BB at -309.47%. Martin Whitman suspects a broader cyclical shift away from heavy investing across the niche.
-566.67%
We cut debt repayment yoy while BB is 0.00%. Joel Greenblatt sees competitor possibly lowering risk more if expansions do not hamper them.
3.55%
Lower share issuance yoy vs. BB's 100.00%, implying less dilution. David Dodd would confirm the firm still has enough capital for expansions.
36.59%
Buyback growth of 36.59% while BB is zero at 0.00%. Bruce Berkowitz sees a modest per-share advantage that might accumulate if the stock is below intrinsic value.